1. Home
  2. MEGL vs CPHI Comparison

MEGL vs CPHI Comparison

Compare MEGL & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magic Empire Global Limited

MEGL

Magic Empire Global Limited

HOLD

Current Price

$1.20

Market Cap

6.6M

Sector

Finance

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.39

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEGL
CPHI
Founded
2016
N/A
Country
Hong Kong
China
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.8M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MEGL
CPHI
Price
$1.20
$1.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.0K
51.2K
Earning Date
12-11-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,296,394.00
$4,052,266.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.20
52 Week High
$5.52
$3.35

Technical Indicators

Market Signals
Indicator
MEGL
CPHI
Relative Strength Index (RSI) 41.76 37.46
Support Level $1.16 $1.35
Resistance Level $1.34 $1.88
Average True Range (ATR) 0.10 0.13
MACD -0.01 -0.03
Stochastic Oscillator 10.43 5.89

Price Performance

Historical Comparison
MEGL
CPHI

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: